Elizabeth G Nabel
CIK 1619929 · View on SEC EDGAR ↗
Insider
First SEC filing: June 16, 2021 · Latest: June 12, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 51 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
51 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 15, 2020 | MRNA | S 10b5-1 | 73,975 | $87.84 | $6,497,964 | 0 Direct | -100.00% | Disposed | 62.9% (price as of 2026-08-21) |
| May 12, 2020 | MRNA | S 10b5-1 | 30,000 | $66.00 | $1,980,000 | 14,344 Direct | -67.65% | Disposed | 116.8% (price as of 2026-08-21) |
| May 12, 2020 | MRNA | S 10b5-1 | 30,000 | $66.00 | $1,980,000 | 14,344 Direct | -67.65% | Disposed | 116.8% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 10, 2026 | LYEL | Option (right to buy) | Common Stock (9,250) | $13.22 | June 9, 2036 | 9,250 | Acquired |
| April 30, 2025 | MRNA | Restricted Stock Units | Common Stock (16,233) | — | — | 16,233 | Acquired |
| April 30, 2025 | MRNA | Restricted Stock Units | Common Stock (979) | — | — | 979 | Disposed |
| June 14, 2024 | LYEL | Option (right to buy) | Common Stock (130,000) | $2.36 | June 13, 2034 | 130,000 | Acquired |
| May 6, 2024 | MRNA | Restricted Stock Units | Common Stock (979) | — | — | 979 | Acquired |
| May 6, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock (5,668) | $122.13 | May 6, 2034 | 5,668 | Acquired |
| May 3, 2024 | MRNA | Restricted Stock Units | Common Stock (732) | — | — | 732 | Disposed |
| Sept. 8, 2023 | LYEL | Option (right to buy) [F1] | Common Stock (55,000) | $3.19 | Sept. 7, 2033 | 55,000 | Acquired |
| June 16, 2023 | LYEL | Option (right to buy) | Common Stock (65,000) | $3.19 | June 15, 2033 | 65,000 | Acquired |
| May 3, 2023 | MRNA | Restricted Stock Units | Common Stock (732) | $0.00 | — | 732 | Acquired |
| May 3, 2023 | MRNA | Stock Option (Right to Buy) | Common Stock (4,601) | $130.14 | May 3, 2033 | 4,601 | Acquired |
| April 28, 2023 | MRNA | Restricted Stock Units | Common Stock (670) | — | — | 670 | Disposed |
| June 8, 2022 | LYEL | Option (right to buy) | Common Stock (65,000) | $5.31 | June 7, 2032 | 65,000 | Acquired |
| April 28, 2022 | MRNA | Restricted Stock Units | Common Stock (670) | $0.00 | — | 670 | Acquired |
| April 28, 2022 | MRNA | Stock Option (Right to Buy) | Common Stock (4,061) | $142.52 | — | 4,061 | Acquired |
| April 28, 2022 | MRNA | Restricted Stock Units | Common Stock (703) | $0.00 | — | 703 | Disposed |
| April 28, 2021 | MRNA | Restricted Stock Units | Common Stock (703) | $0.00 | — | 703 | Acquired |
| April 28, 2021 | MRNA | Stock Option (Right to Buy) | Common Stock (4,081) | $178.68 | April 28, 2031 | 4,081 | Acquired |
| March 10, 2021 | MRNA | Stock Option (Right to Buy) | Common Stock (1,139) | $129.75 | March 10, 2031 | 1,139 | Acquired |
| July 15, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (10,948) | $19.15 | Aug. 10, 2026 | 10,948 | Disposed |
| July 15, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (8,376) | $19.15 | Aug. 10, 2026 | 8,376 | Disposed |
| July 15, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (40,307) | $14.22 | Feb. 28, 2028 | 40,307 | Disposed |
| April 29, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (18,270) | $46.37 | April 29, 2030 | 18,270 | Acquired |
| June 27, 2019 | MRNA | Stock Option (Right to Buy) | Common Stock (54,660) | $14.34 | June 27, 2029 | 54,660 | Acquired |
| Dec. 11, 2018 | MRNA | Series G Preferred Stock | Common Stock (13,679) | — | — | 13,679 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 12 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 16, 2021 | LYEL | Option (right to buy)→ Common Stock (400,000) | 400,000 | Direct |
| Dec. 19, 2018 | HQH | Shares of Beneficial Interest | 2,417 | Direct |
| Dec. 19, 2018 | HQL | Shares of Beneficial Interest | 2,787 | Direct |
| Dec. 19, 2018 | THQ | Shares of Beneficial Interest | 2,816 | Direct |
| Dec. 19, 2018 | THW | Shares of Beneficial Interest | 3,799 | Direct |
| Dec. 7, 2018 | MRNA | Common Stock | 30,665 | Direct |
| Dec. 7, 2018 | MRNA | Series G Preferred Stock→ Common Stock (13,679) | 13,679 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (12,376) | 12,376 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (10,948) | 10,948 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (8,376) | 8,376 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (42,201) | 42,201 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (40,307) | 40,307 | Direct |